Increase of Ceftazidime- and Fluoroquinolone-Resistant Klebsiella pneumoniae and Imipenem-Resistant Acinetobacter spp. in Korea: Analysis of KONSAR Study Data from 2005 and 2007

키워드

참고문헌 (36)

1. Jones RN, "Determining the value of antimicrobial surveillance programs", Diagn Microbiol Infect Dis, 41, pp.171~175 (2001)
2. Morris AK, "Antibiotic resistance surveillance:action for international studies", J Antimicrob Chemother, 49, pp.7~10 (2002)
3. Cornaglia G, "European recommendations for antimicrobial resistance surveillance", Clin Microbiol Infect, 10, pp.349~383 (2004)
4. Llata E, "Measuring the scope and magnitude of hospital-associated infection in the United States: the value of prevalence surveys", Clin Infect Dis, 48, pp.1434~1440 (2009)
5. Chong Y, "Korean Nationwide Surveillance of Antimicrobial Resistance of bacteria in 1997", Yonsei Med J, 39, pp.569~577 (1998)
6. 이경원, "High Prevalence of Ceftazidime-Resistant Klebsiella pneumoniae and Increase of Imipenem-Resistant", Yonsei Medical Journal, 47(5), pp.634~645 (2006), 연세대학교의과대학
7. Lee K, "VIM- and IMP-type metallo-beta-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals", Emerg Infect Dis, 9, pp.868~871 (2003)
8. Kyungwon Lee, "Metallo-β-Lactamase-Producing Pseudomonas spp. in Korea: High Prevalence of Isolates with VIM-2 Type and Emergence of Isolates with IMP-1 Type", Yonsei Medical Journal, 50(3), pp.335~339 (2009), 연세대학교의과대학
9. Lee K, "Wide dissemination of OXA-type carbapenemases in clinical Acinetobacter spp. isolates from South Korea", Int J Antimicrob Agents, 33, pp.520~524 (2009)
10. Lee K, "Prevalence of plasmid-mediated AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae in Korea", Microb Drug Resist, 12, pp.44~49 (2006)
11. Fridkin SK, "Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals", Emerg Infect Dis, 8, pp.697~701 (2002)
12. Van Beneden CA, "Aggregated antibiograms and monitoring of drug-resistant Streptococcus pneumoniae", Emerg Infect Dis, 9, pp.1089~1095 (2003)
13. Bax R, "Surveillance of antimicrobial resistance-what, how and whither?", Clin Microbiol Infect, 7, pp.316~325 (2001)
14. Sahm DF, "Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database-USA", Clin Infect Dis, 29, pp.259~263 (1999)
15. Felmingham D, "The Alexander project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections", J Antimicrob Chemother, 45, pp.191~203 (2000)
16. Jones ME, "Emerging resistance among bacterial pathogens in the intensive care unit - a European and North American Surveillance study (2000-2002)", Ann Clin Microbiol Antimicrob, 3, pp.14~ (2004)
17. Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement, M100-S19", CLSI, ~ (2009)
18. Halstead DC, "Reality of developing a community-wide antibiogram", J Clin Microbiol, 42, pp.1~6 (2004)
19. Lee SO, "Comparison of trends of resistance rates over 3 years calculated from results for all isolates and for the first isolate of a given species from a patient", J Clin Microbiol, 42, pp.4776~4779 (2004)
20. Hidron AI, "NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007", Infect Control Hosp Epidemiol, 29, pp.996~1011 (2008)
21. Peleg AY, "Acinetobacter baumannii:emergence of a successful pathogen", Clin Microbiol Rev, 21, pp.538~582 (2008)
22. Niki Y, "Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2007:general view of the pathogens’ antibacterial susceptibility", J Infect Chemother, 15, pp.156~167 (2009)
23. Styers D, "Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States", Ann Clin Microbiol Antimicrob, 5, pp.2~ (2006)
24. Weinstein MP, "Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae:coping with antimicrobial susceptibility in an era of resistance", Clin Infect Dis, 48, pp.1596~1600 (2009)
25. Song JH, "High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study)", Antimicrob Agents Chemother, 48, pp.2101~2107 (2004)
26. 이경원, "Further Increase of Vancomycin-Resistant Enterococcus faecium, Amikacin- and Fluoroquinolone-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Acinetobacter spp. in Korea", Yonsei Medical Journal, 47(1), pp.43~54 (2006), 연세대학교의과대학
27. Treitman AN, "Emerging incidence of Enterococcus faecium among hospital isolates (1993 to 2002)", J Clin Microbiol, 43, pp.462~463 (2005)
28. 노경호, "First Outbreak of Multidrug-Resistant Klebsiella pneumoniae Producing both SHV-12-Type Extended-Spectrum β-Lactamase and DHA-1-Type AmpC β-Lactamase at a Korean Hospital", Yonsei Medical Journal, 49(1), pp.53~57 (2008), 연세대학교의과대학
29. Bell JM, "Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific Surveillance Program", J Clin Microbiol, 45, pp.1478~1482 (2007)
30. Kitchel B, "Regional dissemination of KPCproducing Klebsiella pneumoniae", Antimicrob Agents Chemother, 53, pp.4511~4513 (2009)
31. Cai JC, "Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing betalactamase KPC-2 in intensive care units of a Chinese hospital", Antimicrob Agents Chemother, 52, pp.2014~2018 (2008)
32. Hasegawa K, "Rapidly increasing prevalence of beta-lactamasenonproducing, ampicillin-resistant Haemophilus influenzae type b in patients with meningitis", Antimicrob Agents Chemother, 48, pp.1509~1514 (2004)
33. Walkty A, "In vitro activity of colistin (polymyxin E) against 3,480 isolates of gram-negative bacilli obtained from patients in Canadian hospitals in the CANWARD Study, 2007-2008", Antimicrob Agents Chemother, 53, pp.4924~4926 (2009)
34. Park YK, "Extreme drug resistance in Acinetobacter baumannii infections in intensive care units, South Korea", Emerg Infect Dis, 15, pp.1325~1327 (2009)
35. Hee Young Yang, "Outbreaks of Imipenem Resistant Acinetobacter Baumannii Producing OXA-23 β-Lactamase in a Tertiary Care Hospital in Korea", Yonsei Medical Journal, 50(6), pp.764~770 (2009), 연세대학교의과대학
36. Livermore DM, "Carbapenemases: a problem in waiting?", Curr Opin Microbiol, 3, pp.489~495 (2000)

관련 논문AI추천